SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 59.74 |
| Enterprise Value ($M) | 1.46 |
| Book Value ($M) | 51.57 |
| Book Value / Share | 1.37 |
| Price / Book | 1.16 |
| NCAV ($M) | 39.97 |
| NCAV / Share | 1.06 |
| Price / NCAV | 1.49 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.29 |
| Return on Assets (ROA) | -0.82 |
| Return on Equity (ROE) | -1.02 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.15 |
| Current Ratio | 3.15 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 68.33 |
| Assets | 79.94 |
| Liabilities | 28.36 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -144.07 |
| Net Income | -138.43 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -119.89 |
| Cash from Investing | -0.36 |
| Cash from Financing | 1.67 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Baker Bros. Advisors Lp | 4.00 | -31.15 | |
| 13G/A | Laurion Capital Management LP | 0.00 | -100.00 | |
| 13G/A | State Street Corp | 1.88 | -84.94 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 245,491 | 810,770 | 30.28 | |
| 200,133 | 575,408 | 34.78 | |
| 167,285 | 810,365 | 20.64 | |
| 229,152 | 639,065 | 35.86 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BEAM – Beam Therapeutics Inc. | BIIB – Biogen Inc. |
| BLUE – bluebird bio, Inc. | BMRN – BioMarin Pharmaceutical Inc. |
| BPMC – Blueprint Medicines Corporation |
Financial data and stock pages provided by
Fintel.io